AU  - Xiang D
FAU  - Xiang, David
AU  - Shah H
FAU  - Shah, Harsh
TI  - Relatlimab and nivolumab provide greater survival benefit for advanced melanoma
PT  - BOOK SECTION
DP  - 2015
BTI  - 2 Minute Medicine
DA  - 2015
Y2  - 2022/07/02
UR  - accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=579756